Vyome Holdings, Inc balance sheet
At the end of fiscal 2025, Vyome Holdings, Inc had total assets of $6.5m, total liabilities of $2.7m and shareholders' equity of $3.8m. It held $5.0m in cash against $0 of debt: net cash of $5.0m.
Balance sheet
| Fiscal year | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7 | 3 | 73 | 21 | 21 | 14 | 3 | 23 | 4 | 4 | 0 | 5 | 8 |
| Receivables | — | — | 0 | 4 | 1 | 0 | 3 | 3 | 2 | 2 | 0 | 0 | 0 |
| Inventory | — | 0 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | 2 | — | — |
| Total current assets | — | 14 | 78 | 52 | 29 | 18 | 9 | 30 | 10 | 10 | 0 | 5 | 8 |
| Total assets | — | 14 | 79 | 53 | 30 | 20 | 37 | 53 | 11 | 11 | 1 | 6 | 9 |
| Accounts payable | — | — | 1 | 1 | 1 | 1 | 4 | 3 | 2 | 2 | 1 | 1 | 1 |
| Deferred revenue (current) | — | — | 0 | 1 | 0 | 0 | — | — | — | — | — | — | — |
| Total current liabilities | — | 6 | 5 | 10 | 17 | 4 | 12 | 8 | 7 | 4 | 6 | 3 | 2 |
| Short-term debt | — | 1 | 0 | 2 | 10 | 0 | 4 | — | — | — | 1 | — | — |
| Long-term debt | — | 9 | 10 | 8 | 0 | 0 | 9 | — | — | — | — | — | — |
| Total debt | 0 | 10 | 10 | 10 | 10 | 0 | 13 | 3 | 0 | 0 | 4 | 0 | 0 |
| Total liabilities | — | 15 | 14 | 18 | 17 | 5 | 23 | 8 | 7 | 4 | 6 | 3 | 2 |
| Shareholders' equity | −40 | −55 | 64 | 35 | 13 | 24 | 14 | 44 | 4 | 7 | −4 | 4 | 7 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 55 | — | — | — | −8 | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | −7 | 6 | −63 | −11 | −11 | −14 | 10 | −20 | −4 | −4 | 3 | −5 | −8 |
| Shares outstanding | — | — | — | — | 19m | — | — | — | — | — | — | — | 7m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Inventory | 3 | 2 | 3 | 3 | — | — | — | — |
| Total current assets | 5 | 0 | 6 | 9 | 6 | 5 | 9 | 8 |
| Total assets | 1 | 1 | 1 | 9 | 7 | 6 | 10 | 9 |
| Accounts payable | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 |
| Total current liabilities | 4 | 6 | 4 | 3 | 3 | 3 | 2 | 2 |
| Short-term debt | — | 1 | — | — | — | — | — | — |
| Total debt | — | 1 | — | — | — | — | — | — |
| Total liabilities | 4 | 6 | 5 | 3 | 3 | 3 | 2 | 2 |
| Shareholders' equity | 1 | −4 | 1 | 6 | 3 | 4 | 8 | 7 |
| Non-controlling interests and other (assets − liabilities − equity) | −4 | — | −5 | — | 1 | — | — | — |
| Shares outstanding | — | — | — | 3m | — | 6m | 7m | 7m |
Compare with peers
- Akanda Corp. balance sheet
- Scienture Holdings, Inc. balance sheet
- PRF Technologies Ltd. balance sheet
- 60 Degrees Pharmaceuticals, Inc. balance sheet
- China SXT Pharmaceuticals, Inc. balance sheet
Head to head: AKAN vs HINDHIND vs SCNXHIND vs PRFX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies